Mr. Thakur has 25 years of experience in managing strategic technology initiatives at Mellon Bank, Conrail, Verizon and IBM. His consulting experience includes advising senior management on technology investment, integration and governance at Pfizer, American Airlines, Investors Bank and Trust, and American Express.
In addition to Microscopy Innovations, Meru is currently a board member at Neoclone Biotechnology. He has served on the board’of other technology start-ups, including SoLoMo and BioSystem Development. He is a member of Silicon Pastures angel network. During his tenure on the BioSystems Development board, a successful exit for investors was achieved through acquisition by Agilent Technologies, Inc. He holds an MBA and a PhD from the Wharton School, University of Pennsylvania.